Insmed Cash Flow Statement
NASDAQ: INSMHealthcareBiotechnologyUSD
100.60+0.12 (+0.12%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insmed free cash flow
In fiscal 2025, Insmed generated -$935.0 million of operating cash flow and spent $32.6 million on capital expenditures. That left free cash flow of -$967.6 million, a free-cash-flow margin of -159.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Insmed cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.28B | -913.77M | -749.57M | -481.53M | -434.65M | -294.09M | -254.34M | -324.28M | -192.65M | -176.27M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 10.45M | 5.96M | 5.50M | 5.30M | 9.10M | 9.10M | 5.20M | 3.60M | 2.90M | 2.40M |
| Stock-Based Compensation | 152.71M | 96.83M | 74.78M | 57.69M | 46.02M | 36.16M | 26.97M | 26.24M | 18.07M | 18.04M |
| Change in Working Capital | -78.18M | -11.51M | -19.14M | 31.82M | -38.70M | 8.20M | -48.68M | -14.19M | 821.00K | 2.96M |
| Operating Cash Flow | -935.01M | -683.88M | -536.25M | -400.44M | -363.30M | -219.35M | -250.65M | -257.98M | -159.62M | -146.71M |
| Capital Expenditures | -32.56M | -21.92M | -13.29M | -9.88M | -7.29M | -6.24M | -42.27M | -13.09M | -3.00M | -4.20M |
| Investing Cash Flow | -64.58M | -583.17M | -223.60M | -34.58M | -64.28M | -6.82M | -42.27M | -14.81M | -3.00M | -4.20M |
| Debt Issued | — | — | — | — | — | — | — | 0 | 0 | 30.00M |
| Debt Repaid | — | — | — | — | — | 0 | 0 | -57.84M | 0 | 0 |
| Financing Cash Flow | 954.07M | 1.34B | 168.44M | 793.27M | 612.55M | 271.00M | 285.28M | 386.74M | 381.09M | 30.67M |
| Net Change in Cash | -44.59M | 72.66M | -591.66M | 357.25M | 184.03M | 45.33M | -7.64M | 113.91M | 218.57M | -120.28M |
| Free Cash Flow | -967.58M | -705.80M | -549.53M | -410.32M | -370.59M | -225.59M | -292.92M | -271.07M | -162.62M | -150.91M |
This table shows 10 annual periods of Insmed's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INSM's reporting calendar. What is a cash flow statement?